Oracle Corp. (NYSE: ORCL) has closed on its previously announced $28.3 billion acquisition of Cerner as it seeks to transform the electronic health records experience. The software giant announced on June 7 that the majority of Cerner shares had been validly tendered. The deal closed yesterday. Cerner is a significant provider of digital information systems […]
Smith+Nephew is moving out of its historic U.K. home
Smith+Nephew (LSE:SN, NYSE:SNN) announced today that it will build a new R&D and manufacturing facility for its Advanced Wound Management franchise that will move the company outside of its historic home of Hull. S+N started in 1856 in Hull. The new R&D and manufacturing hub will be at the Melton West business park — about […]
Moon Surgical raises $31.3M for robotic surgery system
Moon Surgical (Paris and San Francisco) announced today that it has raised $31.3 million in Series A funding to expand its team and accelerate the development of its Maestro robotic surgery system. GT Healthcare Capital & Partners led the round. There was also participation from Johnson & Johnson Innovation – JJDC, Cathay Health — and […]
Sanofi unveils new campus in Massachusetts
Sanofi announced today that it is officially opening its new 900,000-square-foot campus at Cambridge Crossing in Cambridge, Massachusetts. The new campus brings together 2,500 Sanofi Massachusetts-based employees in a shared space. The goal is to improve collaboration between R&D, Medical, and the Specialty Care business unit — and grow a science-centered, patient-focused culture. The Paris-based […]
Ethicon launches next-gen surgical stapler
Johnson & Johnson’s Ethicon today announced the U.S. launch of its next-gen Echelon 3000 stapler. The Echelon 3000 is digitally-enabled and provides surgeons with simple, one-handed powered articulation, according to the Johnson & Johnson (NYSE:JNJ) company. The surgical stapler’s creators designed it with 39% greater jaw aperture and a 27% greater articulation span. The idea […]
What is pulsed-field ablation? Here’s what you need to know
Top experts at Boston Scientific, Medtronic and Acutus Medical shared insights about pulsed-field ablation’s potential at DeviceTalks Boston. Pulsed-field ablation is a non-thermal method for cardiac ablation that has the potential to positively disrupt the way atrial fibrillation is treated. PFA’s roots go back to the dc ablation tech of the 1980s. These days, PFA […]
GE Healthcare says recovery in supply of contrast media is on the way
GE Healthcare (NYSE:GE) announced today that it is on the way toward restabilizing its global supply of iodinated contrast media — a vital imaging agent. The company said its Shanghai facility, previously closed amid COVID-19 restrictions in China, will be close to 100% production capacity by next week. Said GE: “We will continue to work […]
Masimo shareholders vote ‘no’ on executive pay
Masimo (Nasdaq: MASI) shareholders recently voted to advise against the company’s compensation package for top executives. About 52.6% of voting shareholders voted against the patient monitoring tech company’s handling of executive pay in what’s known as the Say-on-Pay vote, according to vote results of the May 26 meeting filed with the SEC yesterday. The vote […]
Boston Scientific opens new office in Dubai
Boston Scientific has officially opened its third Middle Eastern office location, located in TECOM Group’s Dubai Science Park (DSP) in the United Arab Emirates. Eric Thepaut, Executive Vice President and President EMEA at Boston Scientific, said in a Dubai government news release posted yesterday that the company’s investments in the Middle East and North Africa […]
Orthofix announces 5-year positive data for its M6-C artificial cervical disc
Orthofix Medical (Nasdaq:OFIX) today announced positive five-year data from the single-level IDE study of its M6-C artificial cervical disc. Lewisville, Texas–based Orthofix will hold a presentation of the data on June 3 at the International Society for the Advancement of Spine Surgery annual meeting in Nassau, Bahamas. It’s been more than three years since FDA […]
Will Johnson & Johnson buy Boston Scientific?
Needham & Co. analyst Mike Matson today upgraded his rating of Boston Scientific (NYSE:BSX) shares to Buy, partly because he thinks it’s an acquisition target for Johnson & Johnson (NYSE:JNJ). Said Matson: “If JNJ decides to acquire a large medtech company, we believe that BSX could be a good fit.” BSX shares were up more […]